Evidence map›Paper›PMID 26575035›Full record

ArticlePloS one2015

Ssp1 CaMKK: A Sensor of Actin Polarization That Controls Mitotic Commitment through Srk1 in Schizosaccharomyces pombe.

Alba Gómez-Hierro, Eva Lambea, David Giménez-Zaragoza, Sandra López-Avilés, Tula Yance-Chávez, Marta Montserrat, M Jesús Pujol, Oriol Bachs, Rosa Aligue

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Alba Gómez-HierroDepartament de Biologia Cellular, Immunologia i Neurociències, Facultat de Medicina, Universitat de Barcelona, Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Catalunya, Spain.
Eva LambeaDepartament de Biologia Cellular, Immunologia i Neurociències, Facultat de Medicina, Universitat de Barcelona, Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Catalunya, Spain.
David Giménez-ZaragozaDepartament de Biologia Cellular, Immunologia i Neurociències, Facultat de Medicina, Universitat de Barcelona, Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Catalunya, Spain.
Sandra López-AvilésThe Biotechnology Centre of Oslo, Cell Cycle Regulation, Oslo, Norway.
Tula Yance-ChávezDepartament de Biologia Cellular, Immunologia i Neurociències, Facultat de Medicina, Universitat de Barcelona, Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Catalunya, Spain.
Marta MontserratDepartament de Biologia Cellular, Immunologia i Neurociències, Facultat de Medicina, Universitat de Barcelona, Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Catalunya, Spain.
M Jesús PujolDepartament de Biologia Cellular, Immunologia i Neurociències, Facultat de Medicina, Universitat de Barcelona, Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Catalunya, Spain.
Oriol BachsDepartament de Biologia Cellular, Immunologia i Neurociències, Facultat de Medicina, Universitat de Barcelona, Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Catalunya, Spain.
Rosa AligueDepartament de Biologia Cellular, Immunologia i Neurociències, Facultat de Medicina, Universitat de Barcelona, Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, Catalunya, Spain.
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESInstitut d'Investigacions Biomèdiques de Barcelona · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCalcium/calmodulin-dependent protein kinase kinase (CaMKK) is required for diverse cellular functions. Mammalian CaMKK activates CaMKs and also the evolutionarily-conserved AMP-activated protein kinase (AMPK). The fission yeast Schizosaccharomyces pombe CaMKK, Ssp1, is required for tolerance to limited glucose through the AMPK, Ssp2, and for the integration of cell growth and division through the SAD kinase Cdr2.

resultsHere we report that Ssp1 controls the G2/M transition by regulating the activity of the CaMK Srk1. We show that inhibition of Cdc25 by Srk1 is regulated by Ssp1; and also that restoring growth polarity and actin localization of ssp1-deleted cells by removing the actin-monomer-binding protein, twinfilin, is sufficient to suppress the ssp1 phenotype.

conclusionsThese findings demonstrate that entry into mitosis is mediated by a network of proteins, including the Ssp1 and Srk1 kinases. Ssp1 connects the network of components that ensures proper polarity and cell size with the network of proteins that regulates Cdk1-cyclin B activity, in which Srk1 plays an inhibitory role.

Indexed as

ActinsCalcium-Calmodulin-Dependent Protein Kinase KinaseCell Cycle ProteinsHSP70 Heat-Shock ProteinsMicrobial ViabilityMitogen-Activated Protein KinasesMitosisNuclear ProteinsPhosphoprotein PhosphatasesPhosphorylationProtein-Tyrosine KinasesSchizosaccharomycesSchizosaccharomyces pombe ProteinsActinsCalcium-Calmodulin-Dependent Protein Kinase KinaseCdc25 protein, S pombeCell Cycle ProteinsHSP70 Heat-Shock ProteinsMitogen-Activated Protein KinasesNuclear ProteinsPhosphoprotein PhosphatasesProtein-Tyrosine KinasesPSS1 protein, S pombeSchizosaccharomyces pombe ProteinsSRK1 protein, S pombewee1 protein, S pombe

Identifiers

PMID26575035
PMCPMC4648557
OpenAlexW2177770154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.